From canine arthritis to the microbiome, and from the proposed Animal Health Supplement Act to owners’ views on longevity, here is what has been developing for companion animal products.
News|Articles|October 27, 2026
Pet Health Supplements: 2026 Trends for Manufacturers
Author(s)Erin McEvoy
From skin and coat to oral health, a roundup of recent pet supplement research, regulatory signals, and product developments.
Advertisement
Advertisement
Pet supplements continue to draw interest from ingredient suppliers, researchers, and regulators, with recent coverage pointing to species-specific trials, new regulatory recognition, and owners who want evidence alongside palatability. This roundup summarizes pet health findings from Nutritional Outlook’s coverage since late 2025, with a focus on what they mean for supplement manufacturers.
Related to this article
The palm phytonutrient supplier will show STGaia, TocoGaia, and PetGaia at the event and preview a planned research grant program.
The company’s new division offers bovine, porcine, ovine, poultry glandulars for supplements, pet food, and animal feed, highlighting a full QA document package.
A roundup of recent adaptogen trials, newer botanical and fermentation-derived ingredients, and approvals in Canada and South Korea, with a look at the limits of the evidence for manufacturers.
AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.
Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
Advertisement
Advertisement